Strategic Value for Shareholders @Novartis
Strategic Value for Shareholders  @Novartis
Uploaded January 2024 | Updated November 2026, 18 minutes ago
Novartis strategy & value to shareholders were summarized for investors at 2024 J.P. Morgan Healthcare Conference.

With Novartis vision to become the most valued and trusted medicines company in the world, our CEO, Vas Narasimhan, highlighted how our focused strategy, continued investment, and commitment to shareholders support us in achieving this vision during the recent J.P. Morgan Healthcare Conference.

**This video uses audio from the webcasted event.**
J.P. Morgan Healthcare Conference
Event Date: January 08, 2024
Full webcast here: https://go.novartis.social/49012mq
Full presentation here: https://go.novartis.social/3UkSFOy
Novartis JPM HC 2024 Coverage: https://go.novartis.social/47XUyUl
Investor Relations: https://go.novartis.social/3OnNVDE
Investor Events: https://go.novartis.social/483r8Ew
Novartis Strategy: https://go.novartis.social/3Ul99Gf

Disclaimer: J.P. Morgan Healthcare Conference live event contains forward-looking statements. Such forward-looking statements are subject to significant known and unknown risks and uncertainties. Visit our website for more information: https://go.novartis.social/3UkSFOy

The J.P. Morgan Healthcare conference live event also contains non-IFRS measures. An explanation of non-IFRS measures can be found on our website https://go.novartis.social/49aL2OG.

Learn more: https://go.novartis.social/47XUyUl
Strategic Value for ShareholdersSickle cell disease screening a critical step to save lives and improve careDriving the next generation of CAR-T therapyNext Generation Scientist 2023Living with CML: A Patient and Doctor Reflect on Care, Progress and HopeThe Future of Health: Unlocking the power of data to improve urban healthBring your whole self to work at NovartisHow many types of cancer can you name?Keeping a persistent killer on the runNext Generation Scientist 2024S is for Screening webinarInternational Women’s Day 2023
Novartis |

Strategic Value for Shareholders

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER